SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-002617
Filing Date
2022-03-01
Accepted
2022-03-01 17:20:23
Documents
79
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tgtx-20211231x10k.htm   iXBRL 10-K 2547066
2 EX-10.28 tgtx-20211231xex10d28.htm EX-10.28 863691
3 EX-10.29 tgtx-20211231xex10d29.htm EX-10.29 152083
4 EX-10.30 tgtx-20211231xex10d30.htm EX-10.30 160940
5 EX-10.31 tgtx-20211231xex10d31.htm EX-10.31 159651
6 EX-21.1 tgtx-20211231xex21d1.htm EX-21.1 4357
7 EX-23.1 tgtx-20211231xex23d1.htm EX-23.1 2229
8 EX-23.2 tgtx-20211231xex23d2.htm EX-23.2 2249
9 EX-31.1 tgtx-20211231xex31d1.htm EX-31.1 13508
10 EX-31.2 tgtx-20211231xex31d2.htm EX-31.2 13481
11 EX-32.1 tgtx-20211231xex32d1.htm EX-32.1 6628
12 EX-32.2 tgtx-20211231xex32d2.htm EX-32.2 6588
13 GRAPHIC tgtx-20211231x10k001.jpg GRAPHIC 38656
  Complete submission text file 0001558370-22-002617.txt   10076496

Data Files

Seq Description Document Type Size
14 EX-101.SCH tgtx-20211231.xsd EX-101.SCH 53820
15 EX-101.CAL tgtx-20211231_cal.xml EX-101.CAL 65070
16 EX-101.DEF tgtx-20211231_def.xml EX-101.DEF 170715
17 EX-101.LAB tgtx-20211231_lab.xml EX-101.LAB 465031
18 EX-101.PRE tgtx-20211231_pre.xml EX-101.PRE 332930
73 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20211231x10k_htm.xml XML 1378940
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32639 | Film No.: 22699772
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences